Ebola vaccine from GSK to begin U.S. clinical trials within weeks-sources
August 27, 2014 at 18:24 PM EDT
NEW YORK, Aug 27 (Reuters) - U.S. health officials will announce on Thursday that a human study of an Ebola vaccine made by GlaxoSmithKline will begin within a couple of weeks and not later this year as the company estimated originally, according to people familiar with the plans.